GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,425.00p
   
  • Change Today:
      19.00p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,400.00
  • Currency: UK Pounds
  • Shares Issued: 4,067.35m
  • Volume: 8,805,624
  • Market Cap: £57,960m
  • RiskGrade: 129

Latest ShareCast News

GSK to 'vigorously defend' Zantac claims; Haleon says not a party to claims

By Michele Maatouk

Date: Friday 12 Aug 2022

(Sharecast News) - GlaxoSmithKline said on Friday that it would "vigorously defend" all claims related to its discontinued heartburn drug Zantac.

GSK, Haleon, Sanofi slump amid Zantac litigation woes

By Michele Maatouk

Date: Thursday 11 Aug 2022

(Sharecast News) - Shares in GlaxoSmithKline, Haleon and Sanofi tumbled on Thursday amid concerns about legal proceedings related to Glaxo's former blockbuster heartburn drug Zantac.

GSK lifts full-year outlook as Q2 sales rise

By Michele Maatouk

Date: Wednesday 27 Jul 2022

(Sharecast News) - GlaxoSmithKline lifted its full-year outlook on Wednesday as it posted a jump in second-quarter sales.

Citi starts GSK spinoff Haleon at 'buy' 21-Jul-2022 ShareCast
GSK spins off consumer healthcare giant Haleon 18-Jul-2022 ShareCast
Covid-19 cases surge during latest week due to B... 01-Jul-2022 ShareCast
GSK submits shingles vaccine application in Japa... 28-Jun-2022 ShareCast
GlaxoSmithKline to invest £1bn in infectious dis... 23-Jun-2022 ShareCast
GSK says respiratory vaccine shows 'significant'... 10-Jun-2022 ShareCast
GSK's MMR vaccine Priorix gets US FDA approval 06-Jun-2022 ShareCast
GlaxoSmithKline to buy US biotech Affinivax in $... 31-May-2022 ShareCast
GlaxoSmithKline nears deal to build £400m scienc... 30-May-2022 ShareCast
China approves two-dose schedule for GSK's cervi... 27-May-2022 ShareCast
GSK sales top forecasts 27-Apr-2022 ShareCast
US FDA accepts GSK application for kidney diseas... 19-Apr-2022 ShareCast
GSK agrees to buy Sierra Oncology for $1.9bn 13-Apr-2022 ShareCast
GSK's Cabenuva receives approved label update fr... 24-Mar-2022 ShareCast
EU accepts GSK marketing application for kidney ... 01-Mar-2022 ShareCast
GSK to spin off consumer healthcare unit in July 28-Feb-2022 ShareCast
Glaxo halts trial of respiratory virus maternal ... 28-Feb-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,425.00p
Change Today 19.00p
% Change 1.35 %
52 Week High 2,263.00
52 Week Low 1,400.00
Volume 8,805,624
Shares Issued 4,067.35m
Market Cap £57,960m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average
1.59% below the sector average1.59% below the sector average1.59% below the sector average1.59% below the sector average1.59% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 13
Sell 0
Strong Sell 1
Total 22
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 18-Aug-22 19-May-22
Paid 06-Oct-22 01-Jul-22
Amount 16.25p 14.00p

Trades for 16-Aug-2022

Time Volume / Share Price
17:11 7,366 @ 1,425.76p
17:11 35,232 @ 1,428.07p
17:11 29,594 @ 1,424.99p
17:11 37,725 @ 1,429.68p
17:11 19,687 @ 1,435.27p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page